RiverVest
RiverVest Venture Partners is a venture capital firm founded in 2000 that builds and funds life‑science companies, focused on biopharmaceuticals and medical devices. The firm leads financings, founds companies, provides board and operational support, and leverages scientific, clinical, regulatory and reimbursement expertise to advance products that address unmet medical needs while delivering returns to investors.
RiverVest
St Louis, Missouri, United States, North America
Services
Direct and lead financings; company founding
Leads financings, founds companies, structures financing terms and builds investor syndicates to position companies for growth and exit events.
Strategic guidance and operating support
Collaborates with management teams on company strategy, operating plans, hiring and board composition to accelerate product development and commercialization.
Due diligence and scientific evaluation
Provides in‑house diligence and access to a network of scientific, regulatory, clinical and reimbursement experts for investment evaluation and portfolio support.
Follow‑on funding and syndicate support
Provides or helps secure follow‑on financing and connects companies with co‑investors and later‑stage capital sources.
Network access and commercialization support
Provides geographic diversification, access to entrepreneurs, industry investors and commercialization partners, and introductions to scientific and clinical experts.
Direct and lead financings; company founding
Leads financings, founds companies, structures financing terms and builds investor syndicates to position companies for growth and exit events.
Strategic guidance and operating support
Collaborates with management teams on company strategy, operating plans, hiring and board composition to accelerate product development and commercialization.
Due diligence and scientific evaluation
Provides in‑house diligence and access to a network of scientific, regulatory, clinical and reimbursement experts for investment evaluation and portfolio support.
Follow‑on funding and syndicate support
Provides or helps secure follow‑on financing and connects companies with co‑investors and later‑stage capital sources.
Network access and commercialization support
Provides geographic diversification, access to entrepreneurs, industry investors and commercialization partners, and introductions to scientific and clinical experts.
Portfolio
No‑implant approach addressing chronic heart failure; referenced in firm 'Portfolio Company Spotlight'.
#Medical Device
Portfolio company with recent leadership transition (press release referenced).
#Biopharma
Developing inhaled therapies for pulmonary fibrosis; multiple financing and clinical milestones referenced.
#Biopharma
Developing a biowearable platform for metabolic health; announced Series C and strategic collaborations.
#Medical Device
Developing monoclonal antibodies for hepatitis B and D; received FDA breakthrough and EMA designations and advanced clinical trials.
#Biopharma
Developing GLM101 for PMM2‑CDG; announced Series C financing and clinical progress.
#Biopharma
No‑implant approach addressing chronic heart failure; referenced in firm 'Portfolio Company Spotlight'.
#Medical Device
Portfolio company with recent leadership transition (press release referenced).
#Biopharma
Developing inhaled therapies for pulmonary fibrosis; multiple financing and clinical milestones referenced.
#Biopharma
Developing a biowearable platform for metabolic health; announced Series C and strategic collaborations.
#Medical Device
Developing monoclonal antibodies for hepatitis B and D; received FDA breakthrough and EMA designations and advanced clinical trials.
#Biopharma
Developing GLM101 for PMM2‑CDG; announced Series C financing and clinical progress.
#Biopharma